CACLP - The largest IVD Expo & Conference

FDA Grants Emergency Use Authorization for Predicine COVID-19 Test

Industry news | 25 July, 2022 | CACLP

Original from: 360DX


The US Food and Drug Administration this week granted Emergency Use Authorization for a molecular SARS-CoV-2 test from Predicine.


The Predicine SARS-CoV-2 RT-PCR Test is designed to detect viral nucleic acid in anterior nasal specimens collected dry from individuals with or without COVID-19 symptoms using the Predicine COVID-19 Collection Kit. The test is also authorized for use with samples collected at home and with pooled samples containing up to eight specimens.


The test may only be performed by Hayward, California-based Predicine, according to the FDA.


Source: FDA Grants Emergency Use Authorization for Predicine COVID-19 Test

Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference